EBV in MS

The goal of the EBV in MS Platform is to better understand the role of EBV in the development of MS and in ongoing disease; and the potential to target EBV to prevent or treat MS

EBV in MS

The goal of the EBV in MS Platform is to better understand the role of EBV in the development of MS and in ongoing disease; and the potential to target EBV to prevent or treat MS

Crisis Toolkit

Crisis Planning for People Living with a Disability or a Chronic Health Condition

Crisis Toolkit

Crisis Planning for People Living with a Disability or a Chronic Health Condition

You can help take the pain away this Christmas.

Your donation today can help fund new research in to MS-related pain and give people like Emma hope for a pain-free future.

You can help take the pain away this Christmas.

Your donation today can help fund new research in to MS-related pain and give people like Emma hope for a pain-free future.

“PLATYPUS” - PLatform Adaptive Trial for remYelination and neuroProtection in mUltiple Sclerosis - multi-arm, multi-stage (MAMS) clinical trial which will test two repurposed drugs to help people living with progressive MS. 

PLATYPUS

“PLATYPUS” - PLatform Adaptive Trial for remYelination and neuroProtection in mUltiple Sclerosis - multi-arm, multi-stage (MAMS) clinical trial which will test two repurposed drugs to help people living with progressive MS. 

Join us for news and views on the latest research, treatments, and advocacy efforts, as well as candid and informative interviews with our community; those living with MS and their families and carers, together with leading clinicians, researchers, and advocates.

The Raw Nerve Podcast

Join us for news and views on the latest research, treatments, and advocacy efforts, as well as candid and informative interviews with our community; those living with MS and their families and carers, together with leading clinicians, researchers, and advocates.

Trial.Smart provides the background and information to enable empowered choices for people living with MS.

Trial.Smart

Trial.Smart provides the background and information to enable empowered choices for people living with MS.

The Neurological Alliance Australia (NAA) is calling for the establishment of a Taskforce for Neurological Conditions, to urgently address the needs of millions of forgotten Australians.

Count Us In

The Neurological Alliance Australia (NAA) is calling for the establishment of a Taskforce for Neurological Conditions, to urgently address the needs of millions of forgotten Australians.

Our mission: a world without MS

29 November 2024

MS Australia is bringing together the nation’s top researchers to unlock the complex link between EBV) and MS; with the…

27 November 2024

CEO Rohan Greenland reflects on the year’s major developments propelling us towards our key goals – world-leading research, vigorous advocacy,…

27 November 2024

A new study highlights the unique housing and support needs of Australians living with MS, offering insights to improve independence…

27 November 2024

Researchers have found lipids (fats) in cerebrospinal fluid that may help distinguish between NMOSD and MS, as well as track…

25 November 2024

As Des prepares to step down from his role on 28 November 2024, he reflects on a rich career trajectory…

20 November 2024

New study reveals the 16 evidence-based recommendations to improve quality of life and manage complex disease….

18 November 2024

People living with MS and healthcare professionals developed lifestyle recommendations to support brain health in MS, along with strategies to…

15 November 2024

Dr Tennille Luker dives deep into emergency preparedness for people living with MS. Eilish Maguire from Australian Red Cross, Associate…

11 November 2024

Researchers investigated how increased cholesterol production in stem cells from people with PMS may contribute to nerve damage. They found…

4 November 2024

Results from the D-Lay MS study, presented at ECTRIMS 2024, appeared to offer contrasting findings to PrevANZ, yet both reinforce…
Read More

Newsletter subscription

  • Enter your details

Home